All lobbying filings
Todd Strategy Group
Todd Strategy Group filed a Q4 termination report for Lynch Regenerative Medicine, LLC on April 20, 2026, reporting $50,000 in lobbying income.
Lobbying for Lynch Regenerative Medicine, LLC · Bio-technology company.
Filing · LD-2 quarterly report
Q4 termination
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Apr 20, 2026
Income
$50,000
What the client paid this registrant for the period.
Client based in
Tennessee
Representation ended
Dec 31, 2025
The registrant reported terminating its work for this client.
Lobbyists on this filing
3
-
PAUL EDATTELPreviously held: Chief Health Counsel, House Energy & Commerce Committee; Policy Assistant, Office of the Speaker; Professional Staff Member for the Majority at the House Energy & Commerce Committee; Legislative Assistant & Legislative Director, Rep. John Shadegg
-
TED LEHMANPreviously held: Chief of Staff, Senator Tillis; Senate Judiciary Committee-Counsel, then Chief Counsel for Nominations and Senior Counsel; Senate Judiciary Committee-Staff Assistant and Legislative Assistant
-
NICHOLAS UEHLECKEPreviously held: Senior Advisor, Dept. of Health and Human Services; Professional Staff/Sr. Legislative Assistant, House Ways and Means Subcommittee
Government bodies contacted
1
Lobbying activity
1
Implementation of draft Medicare Physician Fee Schedule.